Research memoViatris Inc. (VTRS) · NASDAQMemo of October 23, 2026By Olivier Lachance

Viatris earnings date and guidance

MyStockButler's October 2026 analysis: Viatris reports its next results on November 5, 2026. Viatris’s key test is whether cash generation accelerates while supply remains reliable.

November 5, 2026
Next results
3,756.8
Revenue, quarter to Jun 2026 (US$ millions)
-0.10
EPS, diluted, quarter to Jun 2026
Read the full Viatris memoYour first S&P 500 report is free · no card
Every number traced to Viatris's filings8 chapters · 22,974 words229 sources cited

What has Viatris guided for 2026?

The guidance issued on August 6 calls for 2026 revenue of $14,550 million–$14,950 million. It calls for adjusted EBITDA of $4,300 million–$4,500 million, and adjusted earnings per share of $2.45–$2.59. Adjusted EBITDA measures operating performance before interest, taxes, depreciation and amortization, with further company-defined exclusions. Earnings per share shows the profit assigned to each share.

Viatris guides to $2,050 million–$2,350 million of free cash flow before transaction and restructuring costs in 2026. After those costs, the range falls to $1,450 million–$1,750 million. The difference represents cash that leaves the company even though the adjusted operating measure excludes it. That matters because Pacira, the company Viatris proposes to buy, and shareholder returns will compete for the same dollars.

Viatris (VTRS): Revenue by quarter (US$ millions): Sep 2024 3,751.2, Jun 2026 3,756.8; EPS -$0.10
Guidance in forceUS$ millions
Period guidedLowHighDate given
Total RevenuesYear to Dec 202614,55014,950Aug 6, 2026
Adjusted EBITDAYear to Dec 20264,3004,500Aug 6, 2026
Adjusted EPSYear to Dec 20262.452.59Aug 6, 2026
Free Cash Flow Excluding Transaction-related and Restructuring-related CostsYear to Dec 20262,0502,350Aug 6, 2026
Free Cash FlowYear to Dec 20261,4501,750Aug 6, 2026
Impact of product supply disruptions to total revenuesSecond half of 2026100150Aug 6, 2026

Has Viatris kept its past promises?

Viatris generally delivered its final annual ranges, but it sometimes revised the promise first made. Revenue finished below the benchmark in three of five years checked, while adjusted EBITDA and free cash flow each finished below once. That record earns management a 3/5: delivery improved after revisions, but the original forecasts were not consistently dependable.

Promises kept: 3/5
What management forecastCheckedAboveWithinBelow
Total Revenues5 years203
Adjusted EBITDA5 years221
Free Cash Flow5 years221

What do Viatris’s last eight quarters show?

The June 2026 quarter showed better sales and gross margins, but exceptional charges and supply risk leave the recovery unproved.

The last eight quartersUS$ millions
Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Revenue3,756.83,517.03,703.63,759.93,582.13,254.33,528.13,751.2
Gross margin38.8%32.9%31.0%36.5%37.2%35.7%34.4%38.9%
Operating income6.3-79.7-192.7178.8233.0-2,882.2-179.8225.9
Net income-118.8176.4-340.1-128.2-4.6-3,042.0-516.594.8
EPS, diluted-0.100.15-0.30-0.110.00-2.55-0.430.08
= Free cash flow329.0348.4619.3658.1166.8492.9342.3749.5

What this means. The company can report a loss while still generating positive free cash flow because accounting profit and cash received and spent are measured differently.

What should I watch in Viatris’s next results?

The November 5, 2026 results are the next checkpoint. Investors should ask whether second-half sales remain on course, cash generation accelerates and restructuring costs stay within budget. A profit beat would not settle the issue if inventory builds or customers cannot receive products.

From the full memo · 1. The business

Viatris is a global medicines company that sells familiar brands, generics and more specialized treatments. To understand its business, follow a medicine from development and production through the healthcare system to the cash that remains.

Continue reading, free
Your first S&P 500 report is free · no card

Where these numbers come from

More on Viatris

Viatris stock forecastViatris dividendAuf Deutsch

Browse

All stocksS&P 500 companiesCompanies V
The full Viatris memoYour first S&P 500 report is free
Read it